Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITDALIZE: High-dose Vitamin D3 in Critically Ill Patients With Severe Vitamin D Deficiency
NCT03188796Phase 3Active, not recruiting
- Sponsor
- Medical University of Graz
- Start
- Oct 2017
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
A Phase 3 trial of vitamin d in critical illness, Vitamin D deficiency (VDD), sponsored by Medical University of Graz. Started Oct 2017; status: active, not recruiting.
02
Drugs
vitamin d
03
Conditions
critical illnessVitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03188796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188796.